Vise Technologies, Inc. Astrazeneca PLC Transaction History
Vise Technologies, Inc.
- $771 Million
- Q3 2024
A detailed history of Vise Technologies, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Vise Technologies, Inc. holds 21,544 shares of AZN stock, worth $1.45 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
21,544
Previous 17,217
25.13%
Holding current value
$1.45 Million
Previous $1.34 Million
25.04%
% of portfolio
0.22%
Previous 0.24%
Shares
11 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.23 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.82 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.5 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.47 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.28 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $208B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...